Most Recent

image: Nutrient-Control for GM Bacteria

Nutrient-Control for GM Bacteria

By | January 20, 2016

Genetically modified bacteria that don’t survive unless given an unnatural amino acid could serve as a new control measure to protect wild organisms and ecosystems against accidental release. 

1 Comment

image: Another Role for ApoE?

Another Role for ApoE?

By | January 20, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: Mutant Mosquitoes Deployed to Stop Zika, Dengue

Mutant Mosquitoes Deployed to Stop Zika, Dengue

By | January 19, 2016

A Brazilian town will ramp up the release of insects engineered to shrink mosquito populations.

0 Comments

image: Cocaine Induces Neuronal Autophagy

Cocaine Induces Neuronal Autophagy

By | January 19, 2016

A new study supports the idea that cocaine triggers brain cells to eat themselves and suggests a possible antidote.

2 Comments

image: GM Paper Flagged by Politician Retracted

GM Paper Flagged by Politician Retracted

By | January 18, 2016

One of three suspect publications from a group of scientists in Italy is pulled for plagiarism while an investigation is ongoing.

0 Comments

image: $280 Million Boost for Disease Genomics

$280 Million Boost for Disease Genomics

By | January 18, 2016

The genomics arm of the National Institutes of Health has pledged a total of $280 million for research into the genetic bases of disease.

0 Comments

image: How Blasts Affect the Brain

How Blasts Affect the Brain

By | January 13, 2016

Repeated exposure to explosions can damage the cerebellum in combat veterans and mouse models alike.

0 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Thermo Fisher to Acquire Affymetrix

Thermo Fisher to Acquire Affymetrix

By | January 11, 2016

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.

0 Comments

image: Brain-Training Firm, FTC Settle

Brain-Training Firm, FTC Settle

By | January 6, 2016

San Francisco-based Lumos Labs, creator of the brain-training program Lumosity, will pay $2 million to settle deceptive-advertising charges raised by the US Federal Trade Commission.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS